SKYCLARYS

Welcome to the Brand page for “SKYCLARYS”, which is offered here for Pharmaceutical preparations for the treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy;.

Its status is currently believed to be active. Its class is unavailable. “SKYCLARYS” is believed to be currently owned by “Reata Pharmaceuticals, Inc.”